💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

US companies may delay Colombia investments over government comments, industry body says

Published 08/23/2023, 03:21 PM
Updated 08/23/2023, 03:25 PM
© Reuters. Ricardo Triana, director of the Council of American Businesses (CEA), poses for a photo in Bogota, Colombia August 23, 2023. REUTERS/Nelson Bocanegra

BOGOTA (Reuters) - U.S companies operating in Colombia are not looking to pull out of the South American country, but comments and plans put forward by the government could see them postpone investment decisions, a business association said on Wednesday.

Last week President Gustavo Petro, Colombia's first leftist leader, said he would renegotiate Colombia's free trade agreement with the United States, though two of his ministers later made comments suggesting a softer stance.

The situation is being watched closely by U.S companies, said Lorena Guarnizo, head of corporate matters for the industry group the Council of American Companies.

That kind of comment "quickly results in a postponement to an investment decision or it can slow down that type of thing a bit," she said.

Foreign direct investment in Colombia hit $8.53 billion between January and July, up 22.6% versus the year-earlier period, according to preliminary figures from Colombia's central bank.

"The message from the companies is that they're still in the country, they're still committed to Colombia, no one is saying they want to leave," said Ricardo Triana, director of the CEA.

But companies are trying to establish lines of communication with the Petro administration to work out where they can keep growing and investing, Triana added.

Petro's government is pushing controversial health and pension reforms in Congress and looking to resubmit a labor reform that was rejected during the previous legislative session.

The potential health reform, which seeks to expand access and raise healthcare worker salaries, is especially relevant to some 25 U.S. healthcare companies which belong to CEA, Triana said.

"There's obviously uncertainty regarding this health reform, how it will turn out, what will be approved," he said, adding that a lack of regulatory leadership was also cause for concern.

© Reuters. Ricardo Triana, director of the Council of American Businesses (CEA), poses for a photo in Bogota, Colombia August 23, 2023. REUTERS/Nelson Bocanegra

Colombia's INVIMA food and drugs regulator has not had a director for more than a year, Triana said.

"They are topics that definitely worry the sector," he added.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.